Wanjia Group Holdings Limited (HKG:0401)

Hong Kong · Delayed Price · Currency is HKD

0.0950

-0.0080 (-7.77%)

Sep 29, 2026, 4:08 PM HKT

Market Cap	107.22M +97.3%
Revenue (ttm)	165.39M +2.3%
Net Income	-9.86M
EPS	-0.01
Shares Out	1.13B
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	80,000
Open	0.1120
Previous Close	0.1030
Day's Range	0.0930 - 0.1130
52-Week Range	0.0800 - 0.2090
Beta	1.46
Analysts	n/a
Price Target	n/a
Est. Earnings	Nov 19, 2026

About Wanjia Group Holdings

Wanjia Group Holdings Limited, an investment holding company, engages in the wholesale and distribution pharmaceutical business in the Mainland China and Hong Kong. The company also offers hemodialysis treatment and consultancy services. It sells its products to hospitals and healthcare institutions; and companies operating pharmaceutical retail chain stores, independent pharmacies, outpatient departments of community hospitals, healthcare service stations, and clinics. Wanjia Group Holdings Limited was founded in 2004 and is headquartered in K... [Read more]

Industry Medical Distribution

Sector Healthcare

Founded 2004

Employees 183

Stock Exchange Hong Kong Stock Exchange

Ticker Symbol 0401

Full Company Profile

Financial Performance

In fiscal year 2026, Wanjia Group Holdings's revenue was 165.39 million, an increase of 2.28% compared to the previous year's 161.69 million. Losses were -9.86 million, 49.1% more than in 2025.

Financial Statements